Literature DB >> 11745940

Characterization of new epidemic strains of influenza B virus by using neutralizing monoclonal antibodies.

N Nakagawa1, R Kubota, S Morikawa, T Nakagawa, K Baba, Y Okuno.   

Abstract

During the 1998-1999 influenza season, two distinct influenza B virus Yamagata group strains were isolated from the patients of a private clinic. Each responded differently to monoclonal antibodies (Mabs) 5H4 and 8B3 on staining, and hemagglutination inhibition and neutralizing tests. When the analysis of nucleotide sequences was undertaken, the identity of deduced amino acid sequences of the HA1 region was 94%, which suggested that they derived from different strains. They were termed 5H4-responding strains and 5H4-nonresponding strains, respectively. The analysis of laboratory-induced antigenic variants suggested that the amino acid at position 149 is important to the reactivity to 5H4. This residue was "Arg" in 5H4-responding strains and "Lys" in nonresponding strains. During the 1998-1999 season, a total of 100 influenza B virus strains were isolated and 5H4-responding strains were the major type (94 strains). In the 1999-2000 influenza season, only two influenza B virus strains were isolated. Neither responded to 5H4. However, analysis of the deduced amino acid sequences of the HA1 region suggested that one of the two strains was derived from the 5H4-responding strains of the previous season. The amino acid residue at position 149 was "Lys" in place of "Arg." These observations suggested that 5H4-nonresponding strains will increase in coming seasons. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745940     DOI: 10.1002/jmv.2099

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  Evolution of surface and nonstructural-1 genes of influenza B viruses isolated in the Province of Québec, Canada, during the 1998-2001 period.

Authors:  Yacine Abed; Michael B Coulthart; Yan Li; Guy Boivin
Journal:  Virus Genes       Date:  2003-10       Impact factor: 2.332

2.  A two-tiered model for simulating the ecological and evolutionary dynamics of rapidly evolving viruses, with an application to influenza.

Authors:  Katia Koelle; Priya Khatri; Meredith Kamradt; Thomas B Kepler
Journal:  J R Soc Interface       Date:  2010-03-24       Impact factor: 4.118

3.  Variation of the conserved neutralizing epitope in influenza B virus victoria group isolates in Japan.

Authors:  Naoko Nakagawa; Ritsuko Kubota; Yoshinobu Okuno
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Cocirculation of antigenic variants and the vaccine-type virus during the 2004-2005 influenza B virus epidemics in Japan.

Authors:  Naoko Nakagawa; Natsumi Higashi; Toshimasa Nakagawa
Journal:  J Clin Microbiol       Date:  2008-12-17       Impact factor: 5.948

5.  Influenza B virus victoria group with a new glycosylation site was epidemic in Japan in the 2002-2003 season.

Authors:  Naoko Nakagawa; Ritsuko Kubota; Akiko Maeda; Yoshinobu Okuno
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

6.  Emergence of an influenza B virus with antigenic change.

Authors:  Naoko Nakagawa; Souichi Nukuzuma; Shigekazu Haratome; Shosan Go; Toshimasa Nakagawa; Kozaburo Hayashi
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

7.  Heterogeneous selective pressure acting on influenza B Victoria- and Yamagata-like hemagglutinins.

Authors:  Baltazar Nunes; Pedro Pechirra; Anabela Coelho; Carlos Ribeiro; Ana Arraiolos; Helena Rebelo-de-Andrade
Journal:  J Mol Evol       Date:  2008-10-08       Impact factor: 2.395

8.  Diversifying selective pressure on influenza B virus hemagglutinin.

Authors:  Jun Shen; Brian D Kirk; Jianpeng Ma; Qinghua Wang
Journal:  J Med Virol       Date:  2009-01       Impact factor: 2.327

9.  Crystal structure of unliganded influenza B virus hemagglutinin.

Authors:  Qinghua Wang; Feng Cheng; Mingyang Lu; Xia Tian; Jianpeng Ma
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

10.  Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors.

Authors:  Ritsuko Kubota-Koketsu; Hiroyuki Mizuta; Masatoshi Oshita; Shoji Ideno; Mikihiro Yunoki; Motoki Kuhara; Naomasa Yamamoto; Yoshinobu Okuno; Kazuyoshi Ikuta
Journal:  Biochem Biophys Res Commun       Date:  2009-07-04       Impact factor: 3.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.